Works matching IS 13479032 AND DT 2022 AND VI 113

Results: 399
    1

    Reviewers.

    Published in:
    Cancer Science, 2022, v. 113, n. 12, p. 4401, doi. 10.1111/cas.15670
    Publication type:
    Article
    2
    3

    Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice.

    Published in:
    Cancer Science, 2022, v. 113, n. 12, p. 4300, doi. 10.1111/cas.15586
    By:
    • Ida, Hanae;
    • Koyama, Takafumi;
    • Mizuno, Takaaki;
    • Sunami, Kuniko;
    • Kubo, Takashi;
    • Sudo, Kazuki;
    • Tao, Kayoko;
    • Hirata, Makoto;
    • Yonemori, Kan;
    • Kato, Ken;
    • Okusaka, Takuji;
    • Ohe, Yuichiro;
    • Matsui, Yoshiyuki;
    • Yamazaki, Naoya;
    • Ogawa, Chitose;
    • Kawai, Akira;
    • Narita, Yoshitaka;
    • Esaki, Minoru;
    • Yamamoto, Noboru
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    Pentraxin 3 is an adipose tissue‐related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss.

    Published in:
    Cancer Science, 2022, v. 113, n. 12, p. 4311, doi. 10.1111/cas.15569
    By:
    • Sato, Katsuhiko;
    • Hikita, Hayato;
    • Shigekawa, Minoru;
    • Kato, Seiya;
    • Sasaki, Yoichi;
    • Shinkai, Kazuma;
    • Fukuoka, Makoto;
    • Kudo, Shinnosuke;
    • Sato, Yu;
    • Fukumoto, Kenji;
    • Shirai, Kumiko;
    • Myojin, Yuta;
    • Sakane, Sadatsugu;
    • Murai, Kazuhiro;
    • Yoshioka, Teppei;
    • Nishio, Akira;
    • Kodama, Takahiro;
    • Sakamori, Ryotaro;
    • Tatsumi, Tomohide;
    • Takehara, Tetsuo
    Publication type:
    Article
    12
    13
    14

    Combined chemoradiotherapy and programmed cell death‐ligand 1 blockade leads to changes in the circulating T‐cell receptor repertoire of patients with non‐small‐cell lung cancer.

    Published in:
    Cancer Science, 2022, v. 113, n. 12, p. 4394, doi. 10.1111/cas.15566
    By:
    • Someya, Masanori;
    • Tokita, Serina;
    • Kanaseki, Takayuki;
    • Kitagawa, Mio;
    • Hasegawa, Tomokazu;
    • Tsuchiya, Takaaki;
    • Fukushima, Yuki;
    • Gocho, Toshio;
    • Kozuka, Yoh;
    • Mafune, Shoh;
    • Ikeuchi, Yutaro;
    • Takahashi, Mamoru;
    • Moniwa, Keigo;
    • Matsuo, Kazuhiko;
    • Hasegawa, Tadashi;
    • Torigoe, Toshihiko;
    • Sakata, Koh‐ichi
    Publication type:
    Article
    15

    Pathological complete remission of relapsed tumor by photo‐activating antibody–mimetic drug conjugate treatment.

    Published in:
    Cancer Science, 2022, v. 113, n. 12, p. 4350, doi. 10.1111/cas.15565
    By:
    • Kaneko, Yudai;
    • Yamatsugu, Kenzo;
    • Yamashita, Takefumi;
    • Takahashi, Kazuki;
    • Tanaka, Toshiya;
    • Aki, Sho;
    • Tatsumi, Toshifumi;
    • Kawamura, Takeshi;
    • Miura, Mai;
    • Ishii, Masazumi;
    • Ohkubo, Kei;
    • Osawa, Tsuyoshi;
    • Kodama, Tatsuhiko;
    • Ishikawa, Shumpei;
    • Tsukagoshi, Masanobu;
    • Chansler, Michael;
    • Sugiyama, Akira;
    • Kanai, Motomu;
    • Katoh, Hiroto
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Cancerous pH‐responsive polycarboxybetaine‐coated lipid nanoparticle for smart delivery of siRNA against subcutaneous tumor model in mice.

    Published in:
    Cancer Science, 2022, v. 113, n. 12, p. 4339, doi. 10.1111/cas.15554
    By:
    • Sung, Yi‐Jung;
    • Guo, Haochen;
    • Ghasemizadeh, Aria;
    • Shen, Xin;
    • Chintrakulchai, Wanphiwat;
    • Kobayashi, Motoaki;
    • Toyoda, Masahiro;
    • Ogi, Koichi;
    • Michinishi, Junya;
    • Ohtake, Tomoyuki;
    • Matsui, Makoto;
    • Honda, Yuto;
    • Nomoto, Takahiro;
    • Takemoto, Hiroyasu;
    • Miura, Yutaka;
    • Nishiyama, Nobuhiro
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31

    Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.

    Published in:
    Cancer Science, 2022, v. 113, n. 12, p. 4059, doi. 10.1111/cas.15488
    By:
    • Takahashi, Shuhei;
    • Narita, Shintaro;
    • Fujiyama, Nobuhiro;
    • Hatakeyama, Shingo;
    • Kobayashi, Takashi;
    • Kato, Renpei;
    • Naito, Sei;
    • Sakatani, Toru;
    • Kashima, Soki;
    • Koizumi, Atsushi;
    • Yamamoto, Ryohei;
    • Nara, Taketoshi;
    • Kanda, Souhei;
    • Numakura, Kazuyuki;
    • Saito, Mitsuru;
    • Obara, Wataru;
    • Tsuchiya, Norihiko;
    • Ohyama, Chikara;
    • Ogawa, Osamu;
    • Habuchi, Tomonori
    Publication type:
    Article
    32
    33
    34

    In this Issue.

    Published in:
    Cancer Science, 2022, v. 113, n. 12, p. 4017, doi. 10.1111/cas.14966
    Publication type:
    Article
    35

    Issue Information.

    Published in:
    Cancer Science, 2022, v. 113, n. 12, p. 4013, doi. 10.1111/cas.14965
    Publication type:
    Article
    36

    Correction.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 4013, doi. 10.1111/cas.15588
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44

    Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3912, doi. 10.1111/cas.15539
    By:
    • Otsuka, Hikari;
    • Kita, Yuki;
    • Ito, Katsuhiro;
    • Sano, Takeshi;
    • Inokuchi, Junichi;
    • Tomida, Ryotaro;
    • Takahashi, Atsushi;
    • Matsumoto, Kazumasa;
    • Kurahashi, Ryoma;
    • Ozaki, Yu;
    • Uegaki, Masayuki;
    • Maruyama, Satoru;
    • Mukai, Shoichiro;
    • Tsutsumi, Masakazu;
    • Kawahara, Takashi;
    • Segawa, Takehiko;
    • Kitamura, Hiroshi;
    • Morita, Satoshi;
    • Kobayashi, Takashi
    Publication type:
    Article
    45
    46
    47

    Correction.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 4011, doi. 10.1111/cas.15535
    Publication type:
    Article
    48
    49
    50